Viking Therapeutics Inc. (VKTX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Viking Therapeutics Inc.

NASDAQ: VKTX · Real-Time Price · USD
29.72
1.84 (6.60%)
At close: Oct 03, 2025, 3:59 PM
29.90
0.61%
After-hours: Oct 03, 2025, 07:58 PM EDT

Viking Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
26.68M 55.52M 36.63M 26.37M
Short-Term Investments
875.94M 306.56M 118.85M 175.73M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
102K 139K 71K 109K
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
1.13M 2.52M 3.41M 7.81M
Total Current Assets
907.22M 367.23M 167.04M 210.53M
Property-Plant & Equipment
1M 1.13M 1.42M 25K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
1.1M 1.26M 1.49M 134K
Total Assets
908.32M 368.49M 168.53M 210.66M
Account Payables
9.81M 7.51M 8.53M 1.44M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a 304K 29K
Other Current Liabilities
17.11M n/a -304K -29K
Total Current Liabilities
27.41M 19.14M 21.95M 8.78M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
630K 936K 1.26M n/a
Total Liabilities
28.04M 20.07M 23.21M 8.78M
Total Debt
1.12M 1.26M 1.56M 29K
Book Value
880.28M 348.42M 145.32M 201.88M
Book Value Per Share
8.07 3.69 1.89 2.62
Common Stock
1K 1K 1K 1K
Retained Earnings
-487.91M -377.94M -292.05M -223.18M
Comprehensive Income
-788K -389K -1.1M -549K
Shareholders Equity
880.28M 348.42M 145.32M 201.88M
Total Investments
875.94M 306.56M 118.85M 175.73M